NCT02664077 2022-04-14
ARGO
NSABP Foundation Inc
Phase 3 Terminated
Clinical Trials
4 trialsNCT02425683 2020-02-10
Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX
US Oncology Research
Phase 2 Terminated
NCT02402036 2019-01-29
A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
Georgetown University
Phase 2 Terminated
NCT02119676 2018-02-13
Study of Ruxolitinib in Colorectal Cancer Patients
Incyte Corporation
Phase 2 Terminated